Bryan J Salvatore

EVP Bryan J Salvatore sells 16,394 shares of THG at $185.76 for $3.0M; retains 29,069 shares post-transaction.

Bryan J Salvatore sold 16,394 shares representing -36.1% of his pre-transaction holdings, reducing his stake from 45,463 shares to 29,069 shares at $185.76 per share. The sale occurred when the stock is trading -6.3% from its 52-week high of $199.59, and his cross-ticker track record shows a 90d well-timed rate of 0.00% across 6 prior sells. At THG specifically, his 5 prior sales each showed positive 90-day returns (ranging from +2.0% to +3.0%), indicating those prior sales were not well-timed as the stock rose after each sell. THG trades at a P/E of 9.07 with recent quarterly revenue of $1,701,400,000.00 and annual revenue growth of +5.7%, providing fundamental context for evaluating the trade against market valuation.

THG EVP Salvatore sold 10,526 shares in 3 transactions for $1,753,605.01 on 2025-05-07; holds 25,863 post-sale.

Salvatore Bryan J, Executive Vice President at Hanover Insurance Group, executed 3 separate sales totaling 10,526 shares for $1,753,605.01 on 2025-05-07, reducing his holdings by -28.9% to 25,863 shares. The sales occurred at prices ranging from $166.12 to $167.76 per share (blended average $166.60), close to the current price of $166.24 and within the 52-week range of $120.84–$175.14. His same-ticker prior sales in March 2025 showed modest near-term positive returns (30-day returns of +1.4% to +2.5%), though these outcomes remain incomplete at the 90-day measurement point. The transaction is sized at approximately 28.9% of his pre-transaction holdings, representing a substantial reduction in equity exposure for an executive officer at a company with solid fundamentals (P/E 13.62, $1.6B quarterly revenue, +4.1% annual growth).

EVP Salvatore Bryan J sold 10,526 shares at $172.10 blended average on 2025-03-03 for $1.8M, reducing holdings by 28.9%.

Salvatore Bryan J, Executive Vice President at Hanover Insurance Group, executed 3 separate sales totaling 10,526 shares for $1,811,530.90 on 2025-03-03, reducing his stake from 36,361 to 25,835 shares. The blended average price of $172.10 falls near the current 52-week high of $173.00, and the stock is currently trading at $169.64 after a 10.8% gain over the past 30 days. The 28.9% reduction in his holdings represents a material decrease, though the company's fundamentals remain solid with a P/E of 8.06 and recent quarterly net income of $102.1M. Without a stated trading plan or other context in the filing, the scale and execution of this sale merits investor awareness.